AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2016
Jul 5, 2016
35124_dirs_2016-07-05_563a87f4-5937-40e2-80dc-b65d36695830.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2016-06-30
Reporting Person: Fritz Frederick J. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-06-30 | Celsion Corporation Common Stock | J | 7539 | $1.27 | Acquired | 46870 | Direct |
Footnotes
F1: Director received their quarterly director fees in Celsion Corporation Common Stock in lieu of cash.
F2: The number of shares issued to the director was calculated by dividing the second quarter director fees by the ending stock price of $1.27 on June 30, 2016.
F3: Represents the ending stock price for one share of Celsion Corporation Common Stock on the date of receipt.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23